Evaluation of a Dual PI3K/mTOR Inhibitor PF-04691502 against Bladder Cancer Cells

Targeting the phosphatidylinositol-3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signalling pathway is a promising strategy for the treatment of various cancers, including bladder cancer (BC). PF-04691502 is a relatively novel dual PI3K/mTOR inhibitor that exerts inhibitory...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Xiaosong, Na, Xinyu, Wang, Lei, Yang, Zhiqin, Ren, Pengpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249467/
https://www.ncbi.nlm.nih.gov/pubmed/35783514
http://dx.doi.org/10.1155/2022/8110796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249467/
https://www.ncbi.nlm.nih.gov/pubmed/35783514
http://dx.doi.org/10.1155/2022/8110796

Ejemplares similares